Liu Lanchun, Hu Jun, Mao Qiyuan, Liu Chao, He Haoqiang, Hui Xiaoshan, Yang Guang, Qu Peirong, Lian Wenjing, Duan Lian, Dong Yan, Pan Juhua, Liu Yongmei, He Qingyong, Li Jun, Wang Jie
Departmen of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Departmen of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Front Pharmacol. 2022 Dec 2;13:1034870. doi: 10.3389/fphar.2022.1034870. eCollection 2022.
Ginseng (Panax ginseng C.A.Mey.) is the dry root and rhizome of the Araliaceae ginseng plant. It has always been used as a tonic in China for strengthening the body. Cardiovascular disease is still the main cause of death in the world. Some studies have shown that the functional components of ginseng can regulate the pathological process of various cardiovascular diseases through different mechanisms, and its formulation also plays an irreplaceable role in the clinical treatment of cardiovascular diseases. Therefore, this paper elaborates the current pharmacological effects of ginseng functional components in treating cardiovascular diseases, summarizes the adverse reactions of ginseng, and sorts out the Chinese patent medicines containing ginseng formula which can treat cardiovascular diseases.
人参（Panax ginseng C.A.Mey.）是五加科人参属植物的干燥根及根茎。在中国，它一直被用作强身健体的滋补品。心血管疾病仍然是全球主要的死亡原因。一些研究表明，人参的功能成分可通过不同机制调节各种心血管疾病的病理过程，其制剂在心血管疾病的临床治疗中也发挥着不可替代的作用。因此，本文阐述了人参功能成分目前在治疗心血管疾病方面的药理作用，总结了人参的不良反应，并梳理了含人参配方的可治疗心血管疾病的中成药。
